E-MTAB-5749:Sample 104

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: MRC Toxicology Unit

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: E-MTAB-5749:Sample 104

characteristic: Submitter Id

text: ArrayExpress

characteristic: broker name

text: North America

characteristic: collection site

text: human

characteristic: common name

text: Ganetespib + Docetaxel

text: White

text: adenocarcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: blood

text: death

text: Homo sapiens

text: female

characteristic: sex

text: never smoked

text: IV

text: IV

text: <= 6

text: Sample 104

characteristic: title


E-MTAB-5749:Sample 106

status: PUBLIC

tag: attribute

text: MRC Toxicology Unit

text: public

text: E-MTAB-5749:Sample 106

tag: Namespace:MRC Toxicology Unit

text: ArrayExpress

text: North America

text: human

text: Ganetespib + Docetaxel

characteristic: compound

characteristic: cycles of chemotherapy treatment

text: Protocols: The collection of blood samples from all patients enrolled on the GALAXY-1 trial occurred pre-dose on Cycle 1 Day 1. Blood was drawn into standard EDTA tubes, centrifugation was used to separate plasma. DNA was isolated from 1mL plasma using QIAamp Circulating Nucleic Acid Kits. (Qiagen, Manchester, UK, Cat. # 55114). The GALAXY-1 trial (NCT01348126) randomized lung cancer patients treated with docetaxel with or without the second generation Hsp90 inhibitor ganetespib. In order to explore potential predictive biomarkers, we utilized multiplex targeted NGS of cfDNA taken prior to treatment Library generation followed the protocol described in the Ion AmpliSeq Library Kit 2.0 User Guide. The first 97 samples were analyzed using the Ion AmpliSeq Cancer Hotspot Panel v1. This was superseded by the Ion AmpliSeq Cancer Hotspot Panel v2 during the course of the study, and so the remaining 204 samples were analyzed using the updated sequencing panel

characteristic: description

characteristic: disease progression (binary)

characteristic: eastern cooperative oncology group performance status

text: White

characteristic: ethnic group

text: adenocarcinoma

characteristic: histology

unit: unit per liter

characteristic: lactate dehydrogenase measurement

text: Homo sapiens

text: Homo sapiens

text: blood

characteristic: organism part

text: death

characteristic: organism status

unit: day

characteristic: overall survival

characteristic: progression free survival

text: Homo sapiens

text: female

text: past smoker

characteristic: smoking status

text: IV

characteristic: stage at collection

text: IIIA

characteristic: stage at diagnosis

text: > 6

unit: month

characteristic: time since diagnosis of advanced disease

text: Sample 106

type: has member


E-MTAB-5749:Sample 11

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: MRC Toxicology Unit

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: E-MTAB-5749:Sample 11

characteristic: Submitter Id

text: ArrayExpress

characteristic: broker name

text: Eastern Europe/Russia

characteristic: collection site

text: human

characteristic: common name

text: Ganetespib + Docetaxel

text: White

text: adenocarcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: blood

text: censored

text: Homo sapiens

text: female

characteristic: sex

text: never smoked

text: IV

text: IV

text: > 6

text: Sample 11

characteristic: title


E-MTAB-5749:Sample 111

text: MRC Toxicology Unit

text: public

text: E-MTAB-5749:Sample 111

text: ArrayExpress

text: North America

text: human

text: Ganetespib + Docetaxel

characteristic: compound

characteristic: cycles of chemotherapy treatment

characteristic: description

characteristic: disease progression (binary)

characteristic: eastern cooperative oncology group performance status

text: Asian

characteristic: ethnic group

text: adenocarcinoma

characteristic: histology

characteristic: lactate dehydrogenase measurement

text: Homo sapiens

text: Homo sapiens

text: blood

characteristic: organism part

text: censored

characteristic: organism status

characteristic: overall survival

characteristic: progression free survival

text: Homo sapiens

text: female

text: past smoker

characteristic: smoking status

text: IV

characteristic: stage at collection

text: IIIB

characteristic: stage at diagnosis

text: > 6

characteristic: time since diagnosis of advanced disease

text: Sample 111


E-MTAB-5749:Sample 128

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: MRC Toxicology Unit

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: E-MTAB-5749:Sample 128

characteristic: Submitter Id

text: ArrayExpress

characteristic: broker name

text: Eastern Europe/Russia

characteristic: collection site

text: human

characteristic: common name

text: Ganetespib + Docetaxel

text: White

text: adenocarcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: blood

text: censored

text: Homo sapiens

text: female

characteristic: sex

text: never smoked

text: IV

text: IV

text: > 6

text: Sample 128

characteristic: title


E-MTAB-5749:Sample 129

text: MRC Toxicology Unit

text: public

text: E-MTAB-5749:Sample 129

text: ArrayExpress

text: Eastern Europe/Russia

text: human

text: Ganetespib + Docetaxel

characteristic: compound

characteristic: cycles of chemotherapy treatment

characteristic: description

characteristic: disease progression (binary)

characteristic: eastern cooperative oncology group performance status

text: White

characteristic: ethnic group

text: adenocarcinoma

characteristic: histology

characteristic: lactate dehydrogenase measurement

text: Homo sapiens

text: Homo sapiens

text: blood

characteristic: organism part

text: death

characteristic: organism status

characteristic: overall survival

characteristic: progression free survival

text: Homo sapiens

text: female

text: never smoked

characteristic: smoking status

text: IV

characteristic: stage at collection

text: IV

characteristic: stage at diagnosis

text: > 6

characteristic: time since diagnosis of advanced disease

text: Sample 129


E-MTAB-5749:Sample 134

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: MRC Toxicology Unit

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: E-MTAB-5749:Sample 134

characteristic: Submitter Id

text: ArrayExpress

characteristic: broker name

text: Eastern Europe/Russia

characteristic: collection site

text: human

characteristic: common name

text: Ganetespib + Docetaxel

text: White

text: adenocarcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: blood

text: death

text: Homo sapiens

text: female

characteristic: sex

text: past smoker

text: IV

text: IIIA

text: > 6

text: Sample 134

characteristic: title


E-MTAB-5749:Sample 135

text: MRC Toxicology Unit

text: public

text: E-MTAB-5749:Sample 135

text: ArrayExpress

text: Western Europe

text: human

text: Ganetespib + Docetaxel

characteristic: compound

characteristic: cycles of chemotherapy treatment

characteristic: description

characteristic: disease progression (binary)

characteristic: eastern cooperative oncology group performance status

text: White

characteristic: ethnic group

text: adenocarcinoma

characteristic: histology

characteristic: lactate dehydrogenase measurement

text: Homo sapiens

text: Homo sapiens

text: blood

characteristic: organism part

text: death

characteristic: organism status

characteristic: overall survival

characteristic: progression free survival

text: Homo sapiens

text: female

text: past smoker

characteristic: smoking status

text: IV

characteristic: stage at collection

text: IV

characteristic: stage at diagnosis

text: > 6

characteristic: time since diagnosis of advanced disease

text: Sample 135


E-MTAB-5749:Sample 139

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: MRC Toxicology Unit

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: E-MTAB-5749:Sample 139

characteristic: Submitter Id

text: ArrayExpress

characteristic: broker name

text: Eastern Europe/Russia

characteristic: collection site

text: human

characteristic: common name

text: Ganetespib + Docetaxel

text: White

text: adenocarcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: blood

text: death

text: Homo sapiens

text: female

characteristic: sex

text: never smoked

text: IV

text: IIIB

text: > 6

text: Sample 139

characteristic: title


E-MTAB-5749:Sample 144

text: MRC Toxicology Unit

text: public

text: E-MTAB-5749:Sample 144

text: ArrayExpress

text: Eastern Europe/Russia

text: human

text: Ganetespib + Docetaxel

characteristic: compound

characteristic: cycles of chemotherapy treatment

characteristic: description

characteristic: disease progression (binary)

characteristic: eastern cooperative oncology group performance status

text: White

characteristic: ethnic group

text: adenocarcinoma

characteristic: histology

characteristic: lactate dehydrogenase measurement

text: Homo sapiens

text: Homo sapiens

text: blood

characteristic: organism part

text: death

characteristic: organism status

characteristic: overall survival

characteristic: progression free survival

text: Homo sapiens

text: female

text: never smoked

characteristic: smoking status

text: IV

characteristic: stage at collection

text: IIIA

characteristic: stage at diagnosis

text: > 6

characteristic: time since diagnosis of advanced disease

text: Sample 144


E-MTAB-5749:Sample 162

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: MRC Toxicology Unit

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: E-MTAB-5749:Sample 162

characteristic: Submitter Id

text: ArrayExpress

characteristic: broker name

text: Western Europe

characteristic: collection site

text: human

characteristic: common name

text: Ganetespib + Docetaxel

text: White

text: adenocarcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: blood

text: death

text: Homo sapiens

text: female

characteristic: sex

text: past smoker

text: IV

text: IV

text: <= 6

text: Sample 162

characteristic: title


E-MTAB-5749:Sample 164

text: MRC Toxicology Unit

text: public

text: E-MTAB-5749:Sample 164

text: ArrayExpress

text: Eastern Europe/Russia

text: human

text: Ganetespib + Docetaxel

characteristic: compound

characteristic: cycles of chemotherapy treatment

characteristic: description

characteristic: disease progression (binary)

characteristic: eastern cooperative oncology group performance status

text: White

characteristic: ethnic group

text: adenocarcinoma

characteristic: histology

characteristic: lactate dehydrogenase measurement

text: Homo sapiens

text: Homo sapiens

text: blood

characteristic: organism part

text: death

characteristic: organism status

characteristic: overall survival

characteristic: progression free survival

text: Homo sapiens

text: female

text: past smoker

characteristic: smoking status

text: IV

characteristic: stage at collection

text: IV

characteristic: stage at diagnosis

text: <= 6

characteristic: time since diagnosis of advanced disease

text: Sample 164


E-MTAB-5749:Sample 165

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: MRC Toxicology Unit

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: E-MTAB-5749:Sample 165

characteristic: Submitter Id

text: ArrayExpress

characteristic: broker name

text: Eastern Europe/Russia

characteristic: collection site

text: human

characteristic: common name

text: Ganetespib + Docetaxel

text: White

text: adenocarcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: blood

text: death

text: Homo sapiens

text: female

characteristic: sex

text: never smoked

text: IV

text: IIIB

text: <= 6

text: Sample 165

characteristic: title


E-MTAB-5749:Sample 169

text: MRC Toxicology Unit

text: public

text: E-MTAB-5749:Sample 169

text: ArrayExpress

text: Eastern Europe/Russia

text: human

text: Ganetespib + Docetaxel

characteristic: compound

characteristic: cycles of chemotherapy treatment

characteristic: description

characteristic: disease progression (binary)

characteristic: eastern cooperative oncology group performance status

text: White

characteristic: ethnic group

text: adenocarcinoma

characteristic: histology

characteristic: lactate dehydrogenase measurement

text: Homo sapiens

text: Homo sapiens

text: blood

characteristic: organism part

text: death

characteristic: organism status

characteristic: overall survival

characteristic: progression free survival

text: Homo sapiens

text: female

text: never smoked

characteristic: smoking status

text: IV

characteristic: stage at collection

text: IV

characteristic: stage at diagnosis

text: > 6

characteristic: time since diagnosis of advanced disease

text: Sample 169


E-MTAB-5749:Sample 17

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: MRC Toxicology Unit

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: E-MTAB-5749:Sample 17

characteristic: Submitter Id

text: ArrayExpress

characteristic: broker name

text: Eastern Europe/Russia

characteristic: collection site

text: human

characteristic: common name

text: Ganetespib + Docetaxel

text: White

text: adenocarcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: blood

text: death

text: Homo sapiens

text: female

characteristic: sex

text: never smoked

text: IV

text: IV

text: > 6

text: Sample 17

characteristic: title


E-MTAB-5749:Sample 173

text: MRC Toxicology Unit

text: public

text: E-MTAB-5749:Sample 173

text: ArrayExpress

text: Eastern Europe/Russia

text: human

text: Ganetespib + Docetaxel

characteristic: compound

characteristic: cycles of chemotherapy treatment

characteristic: description

characteristic: disease progression (binary)

characteristic: eastern cooperative oncology group performance status

text: White

characteristic: ethnic group

text: adenocarcinoma

characteristic: histology

characteristic: lactate dehydrogenase measurement

text: Homo sapiens

text: Homo sapiens

text: blood

characteristic: organism part

text: censored

characteristic: organism status

characteristic: overall survival

characteristic: progression free survival

text: Homo sapiens

text: female

text: never smoked

characteristic: smoking status

text: IV

characteristic: stage at collection

text: IV

characteristic: stage at diagnosis

text: > 6

characteristic: time since diagnosis of advanced disease

text: Sample 173


E-MTAB-5749:Sample 177

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: MRC Toxicology Unit

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: E-MTAB-5749:Sample 177

characteristic: Submitter Id

text: ArrayExpress

characteristic: broker name

text: Eastern Europe/Russia

characteristic: collection site

text: human

characteristic: common name

text: Ganetespib + Docetaxel

text: White

text: adenocarcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: blood

text: censored

text: Homo sapiens

text: female

characteristic: sex

text: current smoker

text: IV

text: IV

text: > 6

text: Sample 177

characteristic: title


E-MTAB-5749:Sample 184

text: MRC Toxicology Unit

text: public

text: E-MTAB-5749:Sample 184

text: ArrayExpress

text: Eastern Europe/Russia

text: human

text: Ganetespib + Docetaxel

characteristic: compound

characteristic: cycles of chemotherapy treatment

characteristic: description

characteristic: disease progression (binary)

characteristic: eastern cooperative oncology group performance status

text: White

characteristic: ethnic group

text: adenocarcinoma

characteristic: histology

characteristic: lactate dehydrogenase measurement

text: Homo sapiens

text: Homo sapiens

text: blood

characteristic: organism part

text: death

characteristic: organism status

characteristic: overall survival

characteristic: progression free survival

text: Homo sapiens

text: female

text: never smoked

characteristic: smoking status

text: IV

characteristic: stage at collection

text: IV

characteristic: stage at diagnosis

text: <= 6

characteristic: time since diagnosis of advanced disease

text: Sample 184


E-MTAB-5749:Sample 186

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: MRC Toxicology Unit

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: E-MTAB-5749:Sample 186

characteristic: Submitter Id

text: ArrayExpress

characteristic: broker name

text: Western Europe

characteristic: collection site

text: human

characteristic: common name

text: Ganetespib + Docetaxel

text: White

text: adenocarcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: blood

text: censored

text: Homo sapiens

text: female

characteristic: sex

text: current smoker

text: IV

text: IV

text: > 6

text: Sample 186

characteristic: title


E-MTAB-5749:Sample 189

text: MRC Toxicology Unit

text: public

text: E-MTAB-5749:Sample 189

text: ArrayExpress

text: Western Europe

text: human

text: Ganetespib + Docetaxel

characteristic: compound

characteristic: cycles of chemotherapy treatment

characteristic: description

characteristic: disease progression (binary)

characteristic: eastern cooperative oncology group performance status

text: White

characteristic: ethnic group

text: adenocarcinoma

characteristic: histology

characteristic: lactate dehydrogenase measurement

text: Homo sapiens

text: Homo sapiens

text: blood

characteristic: organism part

text: censored

characteristic: organism status

characteristic: overall survival

characteristic: progression free survival

text: Homo sapiens

text: female

text: past smoker

characteristic: smoking status

text: IV

characteristic: stage at collection

text: IIIA

characteristic: stage at diagnosis

text: > 6

characteristic: time since diagnosis of advanced disease

text: Sample 189


E-MTAB-5749:Sample 190

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: MRC Toxicology Unit

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: E-MTAB-5749:Sample 190

characteristic: Submitter Id

text: ArrayExpress

characteristic: broker name

text: Western Europe

characteristic: collection site

text: human

characteristic: common name

text: Ganetespib + Docetaxel

text: White

text: adenocarcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: blood

text: death

text: Homo sapiens

text: female

characteristic: sex

text: past smoker

text: IV

text: IV

text: > 6

text: Sample 190

characteristic: title


E-MTAB-5749:Sample 194

text: MRC Toxicology Unit

text: public

text: E-MTAB-5749:Sample 194

text: ArrayExpress

text: Eastern Europe/Russia

text: human

text: Ganetespib + Docetaxel

characteristic: compound

characteristic: cycles of chemotherapy treatment

characteristic: description

characteristic: disease progression (binary)

characteristic: eastern cooperative oncology group performance status

text: White

characteristic: ethnic group

text: adenocarcinoma

characteristic: histology

characteristic: lactate dehydrogenase measurement

text: Homo sapiens

text: Homo sapiens

text: blood

characteristic: organism part

text: death

characteristic: organism status

characteristic: overall survival

characteristic: progression free survival

text: Homo sapiens

text: female

text: past smoker

characteristic: smoking status

text: IIIB

characteristic: stage at collection

text: IIIA

characteristic: stage at diagnosis

text: <= 6

characteristic: time since diagnosis of advanced disease

text: Sample 194


E-MTAB-5749:Sample 198

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: MRC Toxicology Unit

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: E-MTAB-5749:Sample 198

characteristic: Submitter Id

text: ArrayExpress

characteristic: broker name

text: Eastern Europe/Russia

characteristic: collection site

text: human

characteristic: common name

text: Ganetespib + Docetaxel

text: White

text: adenocarcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: blood

text: censored

text: Homo sapiens

text: female

characteristic: sex

text: past smoker

text: IV

text: IV

text: > 6

text: Sample 198

characteristic: title


E-MTAB-5749:Sample 206

text: MRC Toxicology Unit

text: public

text: E-MTAB-5749:Sample 206

text: ArrayExpress

text: Eastern Europe/Russia

text: human

text: Ganetespib + Docetaxel

characteristic: compound

characteristic: cycles of chemotherapy treatment

characteristic: description

characteristic: disease progression (binary)

characteristic: eastern cooperative oncology group performance status

text: White

characteristic: ethnic group

text: adenocarcinoma

characteristic: histology

characteristic: lactate dehydrogenase measurement

text: Homo sapiens

text: Homo sapiens

text: blood

characteristic: organism part

text: death

characteristic: organism status

characteristic: overall survival

characteristic: progression free survival

text: Homo sapiens

text: female

text: past smoker

characteristic: smoking status

text: IV

characteristic: stage at collection

text: IV

characteristic: stage at diagnosis

text: <= 6

characteristic: time since diagnosis of advanced disease

text: Sample 206


E-MTAB-5749:Sample 209

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: MRC Toxicology Unit

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: E-MTAB-5749:Sample 209

characteristic: Submitter Id

text: ArrayExpress

characteristic: broker name

text: North America

characteristic: collection site

text: human

characteristic: common name

text: Ganetespib + Docetaxel

text: White

text: adenocarcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: blood

text: death

text: Homo sapiens

text: female

characteristic: sex

text: past smoker

text: IV

text: IV

text: > 6

text: Sample 209

characteristic: title


E-MTAB-5749:Sample 21

text: MRC Toxicology Unit

text: public

text: E-MTAB-5749:Sample 21

text: ArrayExpress

text: Eastern Europe/Russia

text: human

text: Ganetespib + Docetaxel

characteristic: compound

characteristic: cycles of chemotherapy treatment

characteristic: description

characteristic: disease progression (binary)

characteristic: eastern cooperative oncology group performance status

text: White

characteristic: ethnic group

text: adenocarcinoma

characteristic: histology

characteristic: lactate dehydrogenase measurement

text: Homo sapiens

text: Homo sapiens

text: blood

characteristic: organism part

text: censored

characteristic: organism status

characteristic: overall survival

characteristic: progression free survival

text: Homo sapiens

text: female

text: never smoked

characteristic: smoking status

text: IV

characteristic: stage at collection

text: IV

characteristic: stage at diagnosis

text: <= 6

characteristic: time since diagnosis of advanced disease

text: Sample 21


E-MTAB-5749:Sample 211

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: MRC Toxicology Unit

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: E-MTAB-5749:Sample 211

characteristic: Submitter Id

text: ArrayExpress

characteristic: broker name

text: North America

characteristic: collection site

text: human

characteristic: common name

text: Ganetespib + Docetaxel

text: White

text: adenocarcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: blood

text: death

text: Homo sapiens

text: female

characteristic: sex

text: past smoker

text: IV

text: IIIB

text: > 6

text: Sample 211

characteristic: title


E-MTAB-5749:Sample 217

text: MRC Toxicology Unit

text: public

text: E-MTAB-5749:Sample 217

text: ArrayExpress

text: Eastern Europe/Russia

text: human

text: Ganetespib + Docetaxel

characteristic: compound

characteristic: cycles of chemotherapy treatment

characteristic: description

characteristic: disease progression (binary)

characteristic: eastern cooperative oncology group performance status

text: White

characteristic: ethnic group

text: adenocarcinoma

characteristic: histology

characteristic: lactate dehydrogenase measurement

text: Homo sapiens

text: Homo sapiens

text: blood

characteristic: organism part

text: death

characteristic: organism status

characteristic: overall survival

characteristic: progression free survival

text: Homo sapiens

text: female

text: current smoker

characteristic: smoking status

text: IV

characteristic: stage at collection

text: IV

characteristic: stage at diagnosis

text: <= 6

characteristic: time since diagnosis of advanced disease

text: Sample 217


E-MTAB-5749:Sample 219

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: MRC Toxicology Unit

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: E-MTAB-5749:Sample 219

characteristic: Submitter Id

text: ArrayExpress

characteristic: broker name

text: Eastern Europe/Russia

characteristic: collection site

text: human

characteristic: common name

text: Ganetespib + Docetaxel

text: White

text: adenocarcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: blood

text: death

text: Homo sapiens

text: female

characteristic: sex

text: never smoked

text: IV

text: IV

text: > 6

text: Sample 219

characteristic: title


E-MTAB-5749:Sample 226

text: MRC Toxicology Unit

text: public

text: E-MTAB-5749:Sample 226

text: ArrayExpress

text: Eastern Europe/Russia

text: human

text: Ganetespib + Docetaxel

characteristic: compound

characteristic: cycles of chemotherapy treatment

characteristic: description

characteristic: disease progression (binary)

characteristic: eastern cooperative oncology group performance status

text: White

characteristic: ethnic group

text: adenocarcinoma

characteristic: histology

characteristic: lactate dehydrogenase measurement

text: Homo sapiens

text: Homo sapiens

text: blood

characteristic: organism part

text: death

characteristic: organism status

characteristic: overall survival

characteristic: progression free survival

text: Homo sapiens

text: female

text: past smoker

characteristic: smoking status

text: IV

characteristic: stage at collection

text: IIIA

characteristic: stage at diagnosis

text: <= 6

characteristic: time since diagnosis of advanced disease

text: Sample 226


E-MTAB-5749:Sample 229

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: MRC Toxicology Unit

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: E-MTAB-5749:Sample 229

characteristic: Submitter Id

text: ArrayExpress

characteristic: broker name

text: Eastern Europe/Russia

characteristic: collection site

text: human

characteristic: common name

text: Ganetespib + Docetaxel

text: White

text: adenocarcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: blood

text: death

text: Homo sapiens

text: female

characteristic: sex

text: never smoked

text: IV

text: IIIA

text: > 6

text: Sample 229

characteristic: title


E-MTAB-5749:Sample 230

text: MRC Toxicology Unit

text: public

text: E-MTAB-5749:Sample 230

text: ArrayExpress

text: Eastern Europe/Russia

text: human

text: Ganetespib + Docetaxel

characteristic: compound

characteristic: cycles of chemotherapy treatment

characteristic: description

characteristic: disease progression (binary)

characteristic: eastern cooperative oncology group performance status

text: White

characteristic: ethnic group

text: adenocarcinoma

characteristic: histology

characteristic: lactate dehydrogenase measurement

text: Homo sapiens

text: Homo sapiens

text: blood

characteristic: organism part

text: death

characteristic: organism status

characteristic: overall survival

characteristic: progression free survival

text: Homo sapiens

text: female

text: past smoker

characteristic: smoking status

text: IV

characteristic: stage at collection

text: IIIA

characteristic: stage at diagnosis

text: > 6

characteristic: time since diagnosis of advanced disease

text: Sample 230


E-MTAB-5749:Sample 236

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: MRC Toxicology Unit

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: E-MTAB-5749:Sample 236

characteristic: Submitter Id

text: ArrayExpress

characteristic: broker name

text: Western Europe

characteristic: collection site

text: human

characteristic: common name

text: Ganetespib + Docetaxel

text: White

text: adenocarcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: blood

text: death

text: Homo sapiens

text: female

characteristic: sex

text: past smoker

text: IV

text: IIIB

text: > 6

text: Sample 236

characteristic: title


E-MTAB-5749:Sample 243

text: MRC Toxicology Unit

text: public

text: E-MTAB-5749:Sample 243

text: ArrayExpress

text: Eastern Europe/Russia

text: human

text: Ganetespib + Docetaxel

characteristic: compound

characteristic: cycles of chemotherapy treatment

characteristic: description

characteristic: disease progression (binary)

characteristic: eastern cooperative oncology group performance status

text: White

characteristic: ethnic group

text: adenocarcinoma

characteristic: histology

characteristic: lactate dehydrogenase measurement

text: Homo sapiens

text: Homo sapiens

text: blood

characteristic: organism part

text: death

characteristic: organism status

characteristic: overall survival

characteristic: progression free survival

text: Homo sapiens

text: female

text: never smoked

characteristic: smoking status

text: IV

characteristic: stage at collection

text: IV

characteristic: stage at diagnosis

text: > 6

characteristic: time since diagnosis of advanced disease

text: Sample 243


E-MTAB-5749:Sample 25

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: MRC Toxicology Unit

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: E-MTAB-5749:Sample 25

characteristic: Submitter Id

text: ArrayExpress

characteristic: broker name

text: Eastern Europe/Russia

characteristic: collection site

text: human

characteristic: common name

text: Ganetespib + Docetaxel

text: White

text: adenocarcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: blood

text: death

text: Homo sapiens

text: female

characteristic: sex

text: past smoker

text: IV

text: IV

text: > 6

text: Sample 25

characteristic: title


E-MTAB-5749:Sample 257

text: MRC Toxicology Unit

text: public

text: E-MTAB-5749:Sample 257

text: ArrayExpress

text: Eastern Europe/Russia

text: human

text: Ganetespib + Docetaxel

characteristic: compound

characteristic: cycles of chemotherapy treatment

characteristic: description

characteristic: disease progression (binary)

characteristic: eastern cooperative oncology group performance status

text: White

characteristic: ethnic group

text: adenocarcinoma

characteristic: histology

characteristic: lactate dehydrogenase measurement

text: Homo sapiens

text: Homo sapiens

text: blood

characteristic: organism part

text: death

characteristic: organism status

characteristic: overall survival

characteristic: progression free survival

text: Homo sapiens

text: female

text: past smoker

characteristic: smoking status

text: IV

characteristic: stage at collection

text: IV

characteristic: stage at diagnosis

text: <= 6

characteristic: time since diagnosis of advanced disease

text: Sample 257


E-MTAB-5749:Sample 259

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: MRC Toxicology Unit

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: E-MTAB-5749:Sample 259

characteristic: Submitter Id

text: ArrayExpress

characteristic: broker name

text: Eastern Europe/Russia

characteristic: collection site

text: human

characteristic: common name

text: Ganetespib + Docetaxel

text: White

text: adenocarcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: blood

text: death

text: Homo sapiens

text: female

characteristic: sex

text: past smoker

text: IV

text: IV

text: > 6

text: Sample 259

characteristic: title


E-MTAB-5749:Sample 26

text: MRC Toxicology Unit

text: public

text: E-MTAB-5749:Sample 26

text: ArrayExpress

text: Eastern Europe/Russia

text: human

text: Ganetespib + Docetaxel

characteristic: compound

characteristic: cycles of chemotherapy treatment

characteristic: description

characteristic: disease progression (binary)

characteristic: eastern cooperative oncology group performance status

text: White

characteristic: ethnic group

text: adenocarcinoma

characteristic: histology

characteristic: lactate dehydrogenase measurement

text: Homo sapiens

text: Homo sapiens

text: blood

characteristic: organism part

text: death

characteristic: organism status

characteristic: overall survival

characteristic: progression free survival

text: Homo sapiens

text: female

text: never smoked

characteristic: smoking status

text: IV

characteristic: stage at collection

text: IIIB

characteristic: stage at diagnosis

text: > 6

characteristic: time since diagnosis of advanced disease

text: Sample 26


E-MTAB-5749:Sample 261

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: MRC Toxicology Unit

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: E-MTAB-5749:Sample 261

characteristic: Submitter Id

text: ArrayExpress

characteristic: broker name

text: Eastern Europe/Russia

characteristic: collection site

text: human

characteristic: common name

text: Ganetespib + Docetaxel

text: White

text: adenocarcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: blood

text: death

text: Homo sapiens

text: female

characteristic: sex

text: past smoker

text: IV

text: IV

text: > 6

text: Sample 261

characteristic: title


E-MTAB-5749:Sample 262

text: MRC Toxicology Unit

text: public

text: E-MTAB-5749:Sample 262

text: ArrayExpress

text: Eastern Europe/Russia

text: human

text: Ganetespib + Docetaxel

characteristic: compound

characteristic: cycles of chemotherapy treatment

characteristic: description

characteristic: disease progression (binary)

characteristic: eastern cooperative oncology group performance status

text: White

characteristic: ethnic group

text: adenocarcinoma

characteristic: histology

characteristic: lactate dehydrogenase measurement

text: Homo sapiens

text: Homo sapiens

text: blood

characteristic: organism part

text: death

characteristic: organism status

characteristic: overall survival

characteristic: progression free survival

text: Homo sapiens

text: female

text: never smoked

characteristic: smoking status

text: IV

characteristic: stage at collection

text: IV

characteristic: stage at diagnosis

text: <= 6

characteristic: time since diagnosis of advanced disease

text: Sample 262


E-MTAB-5749:Sample 265

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: MRC Toxicology Unit

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: E-MTAB-5749:Sample 265

characteristic: Submitter Id

text: ArrayExpress

characteristic: broker name

text: Eastern Europe/Russia

characteristic: collection site

text: human

characteristic: common name

text: Ganetespib + Docetaxel

text: White

text: adenocarcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: blood

text: death

text: Homo sapiens

text: female

characteristic: sex

text: current smoker

text: IV

text: IV

text: > 6

text: Sample 265

characteristic: title


E-MTAB-5749:Sample 266

text: MRC Toxicology Unit

text: public

text: E-MTAB-5749:Sample 266

text: ArrayExpress

text: Western Europe

text: human

text: Ganetespib + Docetaxel

characteristic: compound

characteristic: cycles of chemotherapy treatment

characteristic: description

characteristic: disease progression (binary)

characteristic: eastern cooperative oncology group performance status

text: Black

characteristic: ethnic group

text: adenocarcinoma

characteristic: histology

characteristic: lactate dehydrogenase measurement

text: Homo sapiens

text: Homo sapiens

text: blood

characteristic: organism part

text: death

characteristic: organism status

characteristic: overall survival

characteristic: progression free survival

text: Homo sapiens

text: female

text: past smoker

characteristic: smoking status

text: IV

characteristic: stage at collection

text: IIIB

characteristic: stage at diagnosis

text: > 6

characteristic: time since diagnosis of advanced disease

text: Sample 266


E-MTAB-5749:Sample 268

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: MRC Toxicology Unit

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: E-MTAB-5749:Sample 268

characteristic: Submitter Id

text: ArrayExpress

characteristic: broker name

text: Eastern Europe/Russia

characteristic: collection site

text: human

characteristic: common name

text: Ganetespib + Docetaxel

text: White

text: adenocarcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: blood

text: censored

text: Homo sapiens

text: female

characteristic: sex

text: current smoker

text: IV

text: IIIB

text: > 6

text: Sample 268

characteristic: title


E-MTAB-5749:Sample 280

text: MRC Toxicology Unit

text: public

text: E-MTAB-5749:Sample 280

text: ArrayExpress

text: Eastern Europe/Russia

text: human

text: Ganetespib + Docetaxel

characteristic: compound

characteristic: cycles of chemotherapy treatment

characteristic: description

characteristic: disease progression (binary)

characteristic: eastern cooperative oncology group performance status

text: White

characteristic: ethnic group

text: adenocarcinoma

characteristic: histology

characteristic: lactate dehydrogenase measurement

text: Homo sapiens

text: Homo sapiens

text: blood

characteristic: organism part

text: censored

characteristic: organism status

characteristic: overall survival

characteristic: progression free survival

text: Homo sapiens

text: female

text: past smoker

characteristic: smoking status

text: IV

characteristic: stage at collection

text: IIIB

characteristic: stage at diagnosis

text: > 6

characteristic: time since diagnosis of advanced disease

text: Sample 280


E-MTAB-5749:Sample 281

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: MRC Toxicology Unit

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: E-MTAB-5749:Sample 281

characteristic: Submitter Id

text: ArrayExpress

characteristic: broker name

text: Eastern Europe/Russia

characteristic: collection site

text: human

characteristic: common name

text: Ganetespib + Docetaxel

text: White

text: adenocarcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: blood

text: death

text: Homo sapiens

text: female

characteristic: sex

text: current smoker

text: IV

text: IV

text: > 6

text: Sample 281

characteristic: title


E-MTAB-5749:Sample 292

text: MRC Toxicology Unit

text: public

text: E-MTAB-5749:Sample 292

text: ArrayExpress

text: Eastern Europe/Russia

text: human

text: Ganetespib + Docetaxel

characteristic: compound

characteristic: cycles of chemotherapy treatment

characteristic: description

characteristic: disease progression (binary)

characteristic: eastern cooperative oncology group performance status

text: White

characteristic: ethnic group

text: adenocarcinoma

characteristic: histology

characteristic: lactate dehydrogenase measurement

text: Homo sapiens

text: Homo sapiens

text: blood

characteristic: organism part

text: death

characteristic: organism status

characteristic: overall survival

characteristic: progression free survival

text: Homo sapiens

text: female

text: past smoker

characteristic: smoking status

text: IIIB

characteristic: stage at collection

text: IIIB

characteristic: stage at diagnosis

text: > 6

characteristic: time since diagnosis of advanced disease

text: Sample 292


E-MTAB-5749:Sample 299

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: MRC Toxicology Unit

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: E-MTAB-5749:Sample 299

characteristic: Submitter Id

text: ArrayExpress

characteristic: broker name

text: North America

characteristic: collection site

text: human

characteristic: common name

text: Ganetespib + Docetaxel

text: White

text: adenocarcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: blood

text: death

text: Homo sapiens

text: female

characteristic: sex

text: past smoker

text: IV

text: I/II

text: > 6

text: Sample 299

characteristic: title


E-MTAB-5749:Sample 3

text: MRC Toxicology Unit

text: public

text: E-MTAB-5749:Sample 3

text: ArrayExpress

text: Eastern Europe/Russia

text: human

text: Ganetespib + Docetaxel

characteristic: compound

characteristic: cycles of chemotherapy treatment

characteristic: description

characteristic: disease progression (binary)

characteristic: eastern cooperative oncology group performance status

text: White

characteristic: ethnic group

text: adenocarcinoma

characteristic: histology

characteristic: lactate dehydrogenase measurement

text: Homo sapiens

text: Homo sapiens

text: blood

characteristic: organism part

text: death

characteristic: organism status

characteristic: overall survival

characteristic: progression free survival

text: Homo sapiens

text: female

text: never smoked

characteristic: smoking status

text: IV

characteristic: stage at collection

text: IV

characteristic: stage at diagnosis

text: > 6

characteristic: time since diagnosis of advanced disease

text: Sample 3


E-MTAB-5749:Sample 30

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: MRC Toxicology Unit

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: E-MTAB-5749:Sample 30

characteristic: Submitter Id

text: ArrayExpress

characteristic: broker name

text: Western Europe

characteristic: collection site

text: human

characteristic: common name

text: Ganetespib + Docetaxel

text: White

text: adenocarcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: blood

text: censored

text: Homo sapiens

text: female

characteristic: sex

text: past smoker

text: IV

text: IV

text: > 6

text: Sample 30

characteristic: title


E-MTAB-5749:Sample 300

text: MRC Toxicology Unit

text: public

text: E-MTAB-5749:Sample 300

text: ArrayExpress

text: North America

text: human

text: Ganetespib + Docetaxel

characteristic: compound

characteristic: cycles of chemotherapy treatment

characteristic: description

characteristic: disease progression (binary)

characteristic: eastern cooperative oncology group performance status

text: White

characteristic: ethnic group

text: adenocarcinoma

characteristic: histology

characteristic: lactate dehydrogenase measurement

text: Homo sapiens

text: Homo sapiens

text: blood

characteristic: organism part

text: censored

characteristic: organism status

characteristic: overall survival

characteristic: progression free survival

text: Homo sapiens

text: female

text: past smoker

characteristic: smoking status

text: IV

characteristic: stage at collection

text: IV

characteristic: stage at diagnosis

text: <= 6

characteristic: time since diagnosis of advanced disease

text: Sample 300


E-MTAB-5749:Sample 301

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: MRC Toxicology Unit

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: E-MTAB-5749:Sample 301

characteristic: Submitter Id

text: ArrayExpress

characteristic: broker name

text: North America

characteristic: collection site

text: human

characteristic: common name

text: Ganetespib + Docetaxel

text: White

text: adenocarcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: blood

text: death

text: Homo sapiens

text: female

characteristic: sex

text: never smoked

text: IV

text: IIIB

text: > 6

text: Sample 301

characteristic: title


E-MTAB-5749:Sample 302

text: MRC Toxicology Unit

text: public

text: E-MTAB-5749:Sample 302

text: ArrayExpress

text: North America

text: human

text: Ganetespib + Docetaxel

characteristic: compound

characteristic: cycles of chemotherapy treatment

characteristic: description

characteristic: disease progression (binary)

characteristic: eastern cooperative oncology group performance status

text: White

characteristic: ethnic group

text: adenocarcinoma

characteristic: histology

characteristic: lactate dehydrogenase measurement

text: Homo sapiens

text: Homo sapiens

text: blood

characteristic: organism part

text: death

characteristic: organism status

characteristic: overall survival

characteristic: progression free survival

text: Homo sapiens

text: female

text: past smoker

characteristic: smoking status

text: IV

characteristic: stage at collection

text: IV

characteristic: stage at diagnosis

text: <= 6

characteristic: time since diagnosis of advanced disease

text: Sample 302


E-MTAB-5749:Sample 305

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: MRC Toxicology Unit

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: E-MTAB-5749:Sample 305

characteristic: Submitter Id

text: ArrayExpress

characteristic: broker name

text: North America

characteristic: collection site

text: human

characteristic: common name

text: Ganetespib + Docetaxel

text: White

text: adenocarcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: blood

text: death

text: Homo sapiens

text: female

characteristic: sex

text: never smoked

text: IV

text: IV

text: <= 6

text: Sample 305

characteristic: title


E-MTAB-5749:Sample 31

text: MRC Toxicology Unit

text: public

text: E-MTAB-5749:Sample 31

text: ArrayExpress

text: Western Europe

text: human

text: Ganetespib + Docetaxel

characteristic: compound

characteristic: cycles of chemotherapy treatment

characteristic: description

characteristic: disease progression (binary)

characteristic: eastern cooperative oncology group performance status

text: White

characteristic: ethnic group

text: adenocarcinoma

characteristic: histology

characteristic: lactate dehydrogenase measurement

text: Homo sapiens

text: Homo sapiens

text: blood

characteristic: organism part

text: death

characteristic: organism status

characteristic: overall survival

characteristic: progression free survival

text: Homo sapiens

text: female

text: never smoked

characteristic: smoking status

text: IV

characteristic: stage at collection

text: IV

characteristic: stage at diagnosis

text: > 6

characteristic: time since diagnosis of advanced disease

text: Sample 31


E-MTAB-5749:Sample 32

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: MRC Toxicology Unit

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: E-MTAB-5749:Sample 32

characteristic: Submitter Id

text: ArrayExpress

characteristic: broker name

text: Western Europe

characteristic: collection site

text: human

characteristic: common name

text: Ganetespib + Docetaxel

text: White

text: adenocarcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: blood

text: censored

text: Homo sapiens

text: female

characteristic: sex

text: past smoker

text: IV

text: IV

text: <= 6

text: Sample 32

characteristic: title


E-MTAB-5749:Sample 39

text: MRC Toxicology Unit

text: public

text: E-MTAB-5749:Sample 39

text: ArrayExpress

text: Eastern Europe/Russia

text: human

text: Ganetespib + Docetaxel

characteristic: compound

characteristic: cycles of chemotherapy treatment

characteristic: description

characteristic: disease progression (binary)

characteristic: eastern cooperative oncology group performance status

text: White

characteristic: ethnic group

text: adenocarcinoma

characteristic: histology

characteristic: lactate dehydrogenase measurement

text: Homo sapiens

text: Homo sapiens

text: blood

characteristic: organism part

text: censored

characteristic: organism status

characteristic: overall survival

characteristic: progression free survival

text: Homo sapiens

text: female

text: never smoked

characteristic: smoking status

text: IV

characteristic: stage at collection

text: IV

characteristic: stage at diagnosis

text: <= 6

characteristic: time since diagnosis of advanced disease

text: Sample 39


E-MTAB-5749:Sample 4

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: MRC Toxicology Unit

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: E-MTAB-5749:Sample 4

characteristic: Submitter Id

text: ArrayExpress

characteristic: broker name

text: Western Europe

characteristic: collection site

text: human

characteristic: common name

text: Ganetespib + Docetaxel

text: White

text: adenocarcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: blood

text: censored

text: Homo sapiens

text: female

characteristic: sex

text: past smoker

text: IV

text: IV

text: > 6

text: Sample 4

characteristic: title


E-MTAB-5749:Sample 5

text: MRC Toxicology Unit

text: public

text: E-MTAB-5749:Sample 5

text: ArrayExpress

text: Western Europe

text: human

text: Ganetespib + Docetaxel

characteristic: compound

characteristic: cycles of chemotherapy treatment

characteristic: description

characteristic: disease progression (binary)

characteristic: eastern cooperative oncology group performance status

text: White

characteristic: ethnic group

text: adenocarcinoma

characteristic: histology

characteristic: lactate dehydrogenase measurement

text: Homo sapiens

text: Homo sapiens

text: blood

characteristic: organism part

text: death

characteristic: organism status

characteristic: overall survival

characteristic: progression free survival

text: Homo sapiens

text: female

text: never smoked

characteristic: smoking status

text: IV

characteristic: stage at collection

text: IV

characteristic: stage at diagnosis

text: <= 6

characteristic: time since diagnosis of advanced disease

text: Sample 5


E-MTAB-5749:Sample 50

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: MRC Toxicology Unit

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: E-MTAB-5749:Sample 50

characteristic: Submitter Id

text: ArrayExpress

characteristic: broker name

text: Western Europe

characteristic: collection site

text: human

characteristic: common name

text: Ganetespib + Docetaxel

text: White

text: adenocarcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: blood

text: death

text: Homo sapiens

text: female

characteristic: sex

text: past smoker

text: IV

text: IV

text: <= 6

text: Sample 50

characteristic: title


E-MTAB-5749:Sample 56

text: MRC Toxicology Unit

text: public

text: E-MTAB-5749:Sample 56

text: ArrayExpress

text: Eastern Europe/Russia

text: human

text: Ganetespib + Docetaxel

characteristic: compound

characteristic: cycles of chemotherapy treatment

characteristic: description

characteristic: disease progression (binary)

characteristic: eastern cooperative oncology group performance status

text: White

characteristic: ethnic group

text: adenocarcinoma

characteristic: histology

characteristic: lactate dehydrogenase measurement

text: Homo sapiens

text: Homo sapiens

text: blood

characteristic: organism part

text: death

characteristic: organism status

characteristic: overall survival

characteristic: progression free survival

text: Homo sapiens

text: female

text: never smoked

characteristic: smoking status

text: IV

characteristic: stage at collection

text: IV

characteristic: stage at diagnosis

text: > 6

characteristic: time since diagnosis of advanced disease

text: Sample 56


E-MTAB-5749:Sample 59

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: MRC Toxicology Unit

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: E-MTAB-5749:Sample 59

characteristic: Submitter Id

text: ArrayExpress

characteristic: broker name

text: Eastern Europe/Russia

characteristic: collection site

text: human

characteristic: common name

text: Ganetespib + Docetaxel

text: White

text: adenocarcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: blood

text: censored

text: Homo sapiens

text: female

characteristic: sex

text: current smoker

text: IV

text: IV

text: > 6

text: Sample 59

characteristic: title


E-MTAB-5749:Sample 61

text: MRC Toxicology Unit

text: public

text: E-MTAB-5749:Sample 61

text: ArrayExpress

text: Eastern Europe/Russia

text: human

text: Ganetespib + Docetaxel

characteristic: compound

characteristic: cycles of chemotherapy treatment

characteristic: description

characteristic: disease progression (binary)

characteristic: eastern cooperative oncology group performance status

text: White

characteristic: ethnic group

text: adenocarcinoma

characteristic: histology

characteristic: lactate dehydrogenase measurement

text: Homo sapiens

text: Homo sapiens

text: blood

characteristic: organism part

text: death

characteristic: organism status

characteristic: overall survival

characteristic: progression free survival

text: Homo sapiens

text: female

text: past smoker

characteristic: smoking status

text: IIIB

characteristic: stage at collection

text: IIIB

characteristic: stage at diagnosis

text: <= 6

characteristic: time since diagnosis of advanced disease

text: Sample 61


E-MTAB-5749:Sample 62

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: MRC Toxicology Unit

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: E-MTAB-5749:Sample 62

characteristic: Submitter Id

text: ArrayExpress

characteristic: broker name

text: Eastern Europe/Russia

characteristic: collection site

text: human

characteristic: common name

text: Ganetespib + Docetaxel

text: White

text: adenocarcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: blood

text: death

text: Homo sapiens

text: female

characteristic: sex

text: current smoker

text: IV

text: IIIB

text: > 6

text: Sample 62

characteristic: title


E-MTAB-5749:Sample 74

text: MRC Toxicology Unit

text: public

text: E-MTAB-5749:Sample 74

text: ArrayExpress

text: Eastern Europe/Russia

text: human

text: Ganetespib + Docetaxel

characteristic: compound

characteristic: cycles of chemotherapy treatment

characteristic: description

characteristic: disease progression (binary)

characteristic: eastern cooperative oncology group performance status

text: White

characteristic: ethnic group

text: adenocarcinoma

characteristic: histology

characteristic: lactate dehydrogenase measurement

text: Homo sapiens

text: Homo sapiens

text: blood

characteristic: organism part

text: censored

characteristic: organism status

characteristic: overall survival

characteristic: progression free survival

text: Homo sapiens

text: female

text: never smoked

characteristic: smoking status

text: IV

characteristic: stage at collection

text: I/II

characteristic: stage at diagnosis

text: <= 6

characteristic: time since diagnosis of advanced disease

text: Sample 74


E-MTAB-5749:Sample 83

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: MRC Toxicology Unit

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: E-MTAB-5749:Sample 83

characteristic: Submitter Id

text: ArrayExpress

characteristic: broker name

text: North America

characteristic: collection site

text: human

characteristic: common name

text: Ganetespib + Docetaxel

text: White

text: adenocarcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: blood

text: death

text: Homo sapiens

text: female

characteristic: sex

text: past smoker

text: IV

text: IV

text: > 6

text: Sample 83

characteristic: title


E-MTAB-5749:Sample 86

text: MRC Toxicology Unit

text: public

text: E-MTAB-5749:Sample 86

text: ArrayExpress

text: Western Europe

text: human

text: Ganetespib + Docetaxel

characteristic: compound

characteristic: cycles of chemotherapy treatment

characteristic: description

characteristic: disease progression (binary)

characteristic: eastern cooperative oncology group performance status

text: White

characteristic: ethnic group

text: adenocarcinoma

characteristic: histology

characteristic: lactate dehydrogenase measurement

text: Homo sapiens

text: Homo sapiens

text: blood

characteristic: organism part

text: death

characteristic: organism status

characteristic: overall survival

characteristic: progression free survival

text: Homo sapiens

text: female

text: past smoker

characteristic: smoking status

text: IV

characteristic: stage at collection

text: IV

characteristic: stage at diagnosis

text: > 6

characteristic: time since diagnosis of advanced disease

text: Sample 86


E-MTAB-5749:Sample 87

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: MRC Toxicology Unit

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: E-MTAB-5749:Sample 87

characteristic: Submitter Id

text: ArrayExpress

characteristic: broker name

text: Eastern Europe/Russia

characteristic: collection site

text: human

characteristic: common name

text: Ganetespib + Docetaxel

text: White

text: adenocarcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: blood

text: censored

text: Homo sapiens

text: female

characteristic: sex

text: never smoked

text: IV

text: IV

text: > 6

text: Sample 87

characteristic: title


E-MTAB-5749:Sample 93

text: MRC Toxicology Unit

text: public

text: E-MTAB-5749:Sample 93

text: ArrayExpress

text: North America

text: human

text: Ganetespib + Docetaxel

characteristic: compound

characteristic: cycles of chemotherapy treatment

characteristic: description

characteristic: disease progression (binary)

characteristic: eastern cooperative oncology group performance status

text: White

characteristic: ethnic group

text: adenocarcinoma

characteristic: histology

characteristic: lactate dehydrogenase measurement

text: Homo sapiens

text: Homo sapiens

text: blood

characteristic: organism part

text: censored

characteristic: organism status

characteristic: overall survival

characteristic: progression free survival

text: Homo sapiens

text: female

text: past smoker

characteristic: smoking status

text: IV

characteristic: stage at collection

text: IV

characteristic: stage at diagnosis

text: > 6

characteristic: time since diagnosis of advanced disease

text: Sample 93


E-MTAB-5749:Sample 99

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: MRC Toxicology Unit

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: E-MTAB-5749:Sample 99

characteristic: Submitter Id

text: ArrayExpress

characteristic: broker name

text: North America

characteristic: collection site

text: human

characteristic: common name

text: Ganetespib + Docetaxel

text: White

text: adenocarcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: blood

text: censored

text: Homo sapiens

text: female

characteristic: sex

text: past smoker

text: IV

text: IV

text: > 6

text: Sample 99

characteristic: title


E-MTAB-5749:Sample 100

text: MRC Toxicology Unit

text: public

text: E-MTAB-5749:Sample 100

text: ArrayExpress

text: North America

text: human

text: Docetaxel

characteristic: compound

characteristic: cycles of chemotherapy treatment

characteristic: description

characteristic: disease progression (binary)

characteristic: eastern cooperative oncology group performance status

text: White

characteristic: ethnic group

text: adenocarcinoma

characteristic: histology

characteristic: lactate dehydrogenase measurement

text: Homo sapiens

text: Homo sapiens

text: blood

characteristic: organism part

text: death

characteristic: organism status

characteristic: overall survival

characteristic: progression free survival

text: Homo sapiens

text: male

text: past smoker

characteristic: smoking status

text: IV

characteristic: stage at collection

text: IV

characteristic: stage at diagnosis

text: > 6

characteristic: time since diagnosis of advanced disease

text: Sample 100


E-MTAB-5749:Sample 105

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: MRC Toxicology Unit

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: E-MTAB-5749:Sample 105

characteristic: Submitter Id

text: ArrayExpress

characteristic: broker name

text: North America

characteristic: collection site

text: human

characteristic: common name

text: Docetaxel

text: White

text: adenocarcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: blood

text: censored

text: Homo sapiens

text: male

characteristic: sex

text: past smoker

text: IV

text: IV

text: > 6

text: Sample 105

characteristic: title


E-MTAB-5749:Sample 107

text: MRC Toxicology Unit

text: public

text: E-MTAB-5749:Sample 107

text: ArrayExpress

text: North America

text: human

text: Docetaxel

characteristic: compound

characteristic: cycles of chemotherapy treatment

characteristic: description

characteristic: disease progression (binary)

characteristic: eastern cooperative oncology group performance status

text: White

characteristic: ethnic group

text: adenocarcinoma

characteristic: histology

characteristic: lactate dehydrogenase measurement

text: Homo sapiens

text: Homo sapiens

text: blood

characteristic: organism part

text: death

characteristic: organism status

characteristic: overall survival

characteristic: progression free survival

text: Homo sapiens

text: male

text: past smoker

characteristic: smoking status

text: IV

characteristic: stage at collection

text: IV

characteristic: stage at diagnosis

text: > 6

characteristic: time since diagnosis of advanced disease

text: Sample 107


E-MTAB-5749:Sample 117

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: MRC Toxicology Unit

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: E-MTAB-5749:Sample 117

characteristic: Submitter Id

text: ArrayExpress

characteristic: broker name

text: North America

characteristic: collection site

text: human

characteristic: common name

text: Docetaxel

text: White

text: adenocarcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: blood

text: death

text: Homo sapiens

text: male

characteristic: sex

text: never smoked

text: IV

text: IV

text: > 6

text: Sample 117

characteristic: title


E-MTAB-5749:Sample 120

text: MRC Toxicology Unit

text: public

text: E-MTAB-5749:Sample 120

text: ArrayExpress

text: Eastern Europe/Russia

text: human

text: Docetaxel

characteristic: compound

characteristic: cycles of chemotherapy treatment

characteristic: description

characteristic: disease progression (binary)

characteristic: eastern cooperative oncology group performance status

text: White

characteristic: ethnic group

text: adenocarcinoma

characteristic: histology

characteristic: lactate dehydrogenase measurement

text: Homo sapiens

text: Homo sapiens

text: blood

characteristic: organism part

text: death

characteristic: organism status

characteristic: overall survival

characteristic: progression free survival

text: Homo sapiens

text: male

text: past smoker

characteristic: smoking status

text: IV

characteristic: stage at collection

text: IIIB

characteristic: stage at diagnosis

text: > 6

characteristic: time since diagnosis of advanced disease

text: Sample 120


E-MTAB-5749:Sample 125

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: MRC Toxicology Unit

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: E-MTAB-5749:Sample 125

characteristic: Submitter Id

text: ArrayExpress

characteristic: broker name

text: Western Europe

characteristic: collection site

text: human

characteristic: common name

text: Docetaxel

text: White

text: adenocarcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: blood

text: censored

text: Homo sapiens

text: male

characteristic: sex

text: past smoker

text: IV

text: IV

text: > 6

text: Sample 125

characteristic: title


E-MTAB-5749:Sample 130

text: MRC Toxicology Unit

text: public

text: E-MTAB-5749:Sample 130

text: ArrayExpress

text: Eastern Europe/Russia

text: human

text: Docetaxel

characteristic: compound

characteristic: cycles of chemotherapy treatment

characteristic: description

characteristic: disease progression (binary)

characteristic: eastern cooperative oncology group performance status

text: White

characteristic: ethnic group

text: adenocarcinoma

characteristic: histology

characteristic: lactate dehydrogenase measurement

text: Homo sapiens

text: Homo sapiens

text: blood

characteristic: organism part

text: censored

characteristic: organism status

characteristic: overall survival

characteristic: progression free survival

text: Homo sapiens

text: male

text: past smoker

characteristic: smoking status

text: IV

characteristic: stage at collection

text: IIIB

characteristic: stage at diagnosis

text: > 6

characteristic: time since diagnosis of advanced disease

text: Sample 130


E-MTAB-5749:Sample 131

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: MRC Toxicology Unit

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: E-MTAB-5749:Sample 131

characteristic: Submitter Id

text: ArrayExpress

characteristic: broker name

text: Eastern Europe/Russia

characteristic: collection site

text: human

characteristic: common name

text: Docetaxel

text: White

text: adenocarcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: blood

text: death

text: Homo sapiens

text: male

characteristic: sex

text: current smoker

text: IV

text: IIIB

text: > 6

text: Sample 131

characteristic: title


E-MTAB-5749:Sample 133

text: MRC Toxicology Unit

text: public

text: E-MTAB-5749:Sample 133

text: ArrayExpress

text: Eastern Europe/Russia

text: human

text: Docetaxel

characteristic: compound

characteristic: cycles of chemotherapy treatment

characteristic: description

characteristic: disease progression (binary)

characteristic: eastern cooperative oncology group performance status

text: White

characteristic: ethnic group

text: adenocarcinoma

characteristic: histology

characteristic: lactate dehydrogenase measurement

text: Homo sapiens

text: Homo sapiens

text: blood

characteristic: organism part

text: censored

characteristic: organism status

characteristic: overall survival

characteristic: progression free survival

text: Homo sapiens

text: male

text: never smoked

characteristic: smoking status

text: IV

characteristic: stage at collection

text: I/II

characteristic: stage at diagnosis

text: <= 6

characteristic: time since diagnosis of advanced disease

text: Sample 133


E-MTAB-5749:Sample 140

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: MRC Toxicology Unit

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: E-MTAB-5749:Sample 140

characteristic: Submitter Id

text: ArrayExpress

characteristic: broker name

text: Eastern Europe/Russia

characteristic: collection site

text: human

characteristic: common name

text: Docetaxel

text: White

text: adenocarcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: blood

text: death

text: Homo sapiens

text: male

characteristic: sex

text: past smoker

text: IV

text: IIIB

text: > 6

text: Sample 140

characteristic: title


E-MTAB-5749:Sample 142

text: MRC Toxicology Unit

text: public

text: E-MTAB-5749:Sample 142

text: ArrayExpress

text: Eastern Europe/Russia

text: human

text: Docetaxel

characteristic: compound

characteristic: cycles of chemotherapy treatment

characteristic: description

characteristic: disease progression (binary)

characteristic: eastern cooperative oncology group performance status

text: White

characteristic: ethnic group

text: adenocarcinoma

characteristic: histology

characteristic: lactate dehydrogenase measurement

text: Homo sapiens

text: Homo sapiens

text: blood

characteristic: organism part

text: death

characteristic: organism status

characteristic: overall survival

characteristic: progression free survival

text: Homo sapiens

text: male

text: past smoker

characteristic: smoking status

text: IV

characteristic: stage at collection

text: IV

characteristic: stage at diagnosis

text: > 6

characteristic: time since diagnosis of advanced disease

text: Sample 142


E-MTAB-5749:Sample 145

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: MRC Toxicology Unit

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: E-MTAB-5749:Sample 145

characteristic: Submitter Id

text: ArrayExpress

characteristic: broker name

text: Eastern Europe/Russia

characteristic: collection site

text: human

characteristic: common name

text: Docetaxel

text: White

text: adenocarcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: blood

text: censored

text: Homo sapiens

text: male

characteristic: sex

text: never smoked

text: IV

text: IV

text: > 6

text: Sample 145

characteristic: title


E-MTAB-5749:Sample 146

text: MRC Toxicology Unit

text: public

text: E-MTAB-5749:Sample 146

text: ArrayExpress

text: Eastern Europe/Russia

text: human

text: Docetaxel

characteristic: compound

characteristic: cycles of chemotherapy treatment

characteristic: description

characteristic: disease progression (binary)

characteristic: eastern cooperative oncology group performance status

text: White

characteristic: ethnic group

text: adenocarcinoma

characteristic: histology

characteristic: lactate dehydrogenase measurement

text: Homo sapiens

text: Homo sapiens

text: blood

characteristic: organism part

text: death

characteristic: organism status

characteristic: overall survival

characteristic: progression free survival

text: Homo sapiens

text: male

text: past smoker

characteristic: smoking status

text: IV

characteristic: stage at collection

text: IV

characteristic: stage at diagnosis

text: <= 6

characteristic: time since diagnosis of advanced disease

text: Sample 146


E-MTAB-5749:Sample 147

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: MRC Toxicology Unit

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: E-MTAB-5749:Sample 147

characteristic: Submitter Id

text: ArrayExpress

characteristic: broker name

text: Western Europe

characteristic: collection site

text: human

characteristic: common name

text: Docetaxel

text: White

text: adenocarcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: blood

text: death

text: Homo sapiens

text: male

characteristic: sex

text: current smoker

text: IV

text: IV

text: > 6

text: Sample 147

characteristic: title


E-MTAB-5749:Sample 149

text: MRC Toxicology Unit

text: public

text: E-MTAB-5749:Sample 149

text: ArrayExpress

text: Western Europe

text: human

text: Docetaxel

characteristic: compound

characteristic: cycles of chemotherapy treatment

characteristic: description

characteristic: disease progression (binary)

characteristic: eastern cooperative oncology group performance status

text: White

characteristic: ethnic group

text: adenocarcinoma

characteristic: histology

characteristic: lactate dehydrogenase measurement

text: Homo sapiens

text: Homo sapiens

text: blood

characteristic: organism part

text: death

characteristic: organism status

characteristic: overall survival

characteristic: progression free survival

text: Homo sapiens

text: male

text: past smoker

characteristic: smoking status

text: IV

characteristic: stage at collection

text: IV

characteristic: stage at diagnosis

text: > 6

characteristic: time since diagnosis of advanced disease

text: Sample 149


E-MTAB-5749:Sample 15

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: MRC Toxicology Unit

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: E-MTAB-5749:Sample 15

characteristic: Submitter Id

text: ArrayExpress

characteristic: broker name

text: Eastern Europe/Russia

characteristic: collection site

text: human

characteristic: common name

text: Docetaxel

text: White

text: adenocarcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: blood

text: censored

text: Homo sapiens

text: male

characteristic: sex

text: current smoker

text: IV

text: IV

text: > 6

text: Sample 15

characteristic: title


E-MTAB-5749:Sample 151

text: MRC Toxicology Unit

text: public

text: E-MTAB-5749:Sample 151

text: ArrayExpress

text: Western Europe

text: human

text: Docetaxel

characteristic: compound

characteristic: cycles of chemotherapy treatment

characteristic: description

characteristic: disease progression (binary)

characteristic: eastern cooperative oncology group performance status

text: White

characteristic: ethnic group

text: adenocarcinoma

characteristic: histology

characteristic: lactate dehydrogenase measurement

text: Homo sapiens

text: Homo sapiens

text: blood

characteristic: organism part

text: death

characteristic: organism status

characteristic: overall survival

characteristic: progression free survival

text: Homo sapiens

text: male

text: past smoker

characteristic: smoking status

text: IV

characteristic: stage at collection

text: IV

characteristic: stage at diagnosis

text: > 6

characteristic: time since diagnosis of advanced disease

text: Sample 151


E-MTAB-5749:Sample 153

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: MRC Toxicology Unit

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: E-MTAB-5749:Sample 153

characteristic: Submitter Id

text: ArrayExpress

characteristic: broker name

text: Eastern Europe/Russia

characteristic: collection site

text: human

characteristic: common name

text: Docetaxel

text: White

text: adenocarcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: blood

text: censored

text: Homo sapiens

text: male

characteristic: sex

text: past smoker

text: IV

text: IV

text: > 6

text: Sample 153

characteristic: title


E-MTAB-5749:Sample 158

text: MRC Toxicology Unit

text: public

text: E-MTAB-5749:Sample 158

text: ArrayExpress

text: Eastern Europe/Russia

text: human

text: Docetaxel

characteristic: compound

characteristic: cycles of chemotherapy treatment

characteristic: description

characteristic: disease progression (binary)

characteristic: eastern cooperative oncology group performance status

text: White

characteristic: ethnic group

text: adenocarcinoma

characteristic: histology

characteristic: lactate dehydrogenase measurement

text: Homo sapiens

text: Homo sapiens

text: blood

characteristic: organism part

text: death

characteristic: organism status

characteristic: overall survival

characteristic: progression free survival

text: Homo sapiens

text: male

text: current smoker

characteristic: smoking status

text: IV

characteristic: stage at collection

text: IV

characteristic: stage at diagnosis

text: <= 6

characteristic: time since diagnosis of advanced disease

text: Sample 158


E-MTAB-5749:Sample 16

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: MRC Toxicology Unit

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: E-MTAB-5749:Sample 16

characteristic: Submitter Id

text: ArrayExpress

characteristic: broker name

text: Eastern Europe/Russia

characteristic: collection site

text: human

characteristic: common name

text: Docetaxel

text: White

text: adenocarcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: blood

text: censored

text: Homo sapiens

text: male

characteristic: sex

text: past smoker

text: IV

text: IV

text: <= 6

text: Sample 16

characteristic: title


E-MTAB-5749:Sample 160

text: MRC Toxicology Unit

text: public

text: E-MTAB-5749:Sample 160

text: ArrayExpress

text: Western Europe

text: human

text: Docetaxel

characteristic: compound

characteristic: cycles of chemotherapy treatment

characteristic: description

characteristic: disease progression (binary)

characteristic: eastern cooperative oncology group performance status

text: White

characteristic: ethnic group

text: adenocarcinoma

characteristic: histology

characteristic: lactate dehydrogenase measurement

text: Homo sapiens

text: Homo sapiens

text: blood

characteristic: organism part

text: death

characteristic: organism status

characteristic: overall survival

characteristic: progression free survival

text: Homo sapiens

text: male

text: current smoker

characteristic: smoking status

text: IV

characteristic: stage at collection

text: IV

characteristic: stage at diagnosis

text: <= 6

characteristic: time since diagnosis of advanced disease

text: Sample 160


E-MTAB-5749:Sample 167

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: MRC Toxicology Unit

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: E-MTAB-5749:Sample 167

characteristic: Submitter Id

text: ArrayExpress

characteristic: broker name

text: Eastern Europe/Russia

characteristic: collection site

text: human

characteristic: common name

text: Docetaxel

text: White

text: adenocarcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: blood

text: death

text: Homo sapiens

text: male

characteristic: sex

text: past smoker

text: IV

text: I/II

text: <= 6

text: Sample 167

characteristic: title


E-MTAB-5749:Sample 168

text: MRC Toxicology Unit

text: public

text: E-MTAB-5749:Sample 168

text: ArrayExpress

text: Eastern Europe/Russia

text: human

text: Docetaxel

characteristic: compound

characteristic: cycles of chemotherapy treatment

characteristic: description

characteristic: disease progression (binary)

characteristic: eastern cooperative oncology group performance status

text: White

characteristic: ethnic group

text: adenocarcinoma

characteristic: histology

characteristic: lactate dehydrogenase measurement

text: Homo sapiens

text: Homo sapiens

text: blood

characteristic: organism part

text: death

characteristic: organism status

characteristic: overall survival

characteristic: progression free survival

text: Homo sapiens

text: male

text: past smoker

characteristic: smoking status

text: IV

characteristic: stage at collection

text: I/II

characteristic: stage at diagnosis

text: > 6

characteristic: time since diagnosis of advanced disease

text: Sample 168


E-MTAB-5749:Sample 172

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: MRC Toxicology Unit

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: E-MTAB-5749:Sample 172

characteristic: Submitter Id

text: ArrayExpress

characteristic: broker name

text: Eastern Europe/Russia

characteristic: collection site

text: human

characteristic: common name

text: Docetaxel

text: White

text: adenocarcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: blood

text: death

text: Homo sapiens

text: male

characteristic: sex

text: current smoker

text: IV

text: IV

text: > 6

text: Sample 172

characteristic: title


E-MTAB-5749:Sample 175

text: MRC Toxicology Unit

text: public

text: E-MTAB-5749:Sample 175

text: ArrayExpress

text: Eastern Europe/Russia

text: human

text: Docetaxel

characteristic: compound

characteristic: cycles of chemotherapy treatment

characteristic: description

characteristic: disease progression (binary)

characteristic: eastern cooperative oncology group performance status

text: White

characteristic: ethnic group

text: adenocarcinoma

characteristic: histology

characteristic: lactate dehydrogenase measurement

text: Homo sapiens

text: Homo sapiens

text: blood

characteristic: organism part

text: censored

characteristic: organism status

characteristic: overall survival

characteristic: progression free survival

text: Homo sapiens

text: male

text: past smoker

characteristic: smoking status

text: IV

characteristic: stage at collection

text: IV

characteristic: stage at diagnosis

text: > 6

characteristic: time since diagnosis of advanced disease

text: Sample 175


E-MTAB-5749:Sample 179

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: MRC Toxicology Unit

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: E-MTAB-5749:Sample 179

characteristic: Submitter Id

text: ArrayExpress

characteristic: broker name

text: Eastern Europe/Russia

characteristic: collection site

text: human

characteristic: common name

text: Docetaxel

text: White

text: adenocarcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: blood

text: death

text: Homo sapiens

text: male

characteristic: sex

text: past smoker

text: IIIB

text: IIIB

text: > 6

text: Sample 179

characteristic: title


E-MTAB-5749:Sample 181

text: MRC Toxicology Unit

text: public

text: E-MTAB-5749:Sample 181

text: ArrayExpress

text: Eastern Europe/Russia

text: human

text: Docetaxel

characteristic: compound

characteristic: cycles of chemotherapy treatment

characteristic: description

characteristic: disease progression (binary)

characteristic: eastern cooperative oncology group performance status

text: White

characteristic: ethnic group

text: adenocarcinoma

characteristic: histology

characteristic: lactate dehydrogenase measurement

text: Homo sapiens

text: Homo sapiens

text: blood

characteristic: organism part

text: death

characteristic: organism status

characteristic: overall survival

characteristic: progression free survival

text: Homo sapiens

text: male

text: past smoker

characteristic: smoking status

text: IV

characteristic: stage at collection

text: IV

characteristic: stage at diagnosis

text: > 6

characteristic: time since diagnosis of advanced disease

text: Sample 181


E-MTAB-5749:Sample 182

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: MRC Toxicology Unit

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: E-MTAB-5749:Sample 182

characteristic: Submitter Id

text: ArrayExpress

characteristic: broker name

text: Eastern Europe/Russia

characteristic: collection site

text: human

characteristic: common name

text: Docetaxel

text: White

text: adenocarcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: blood

text: death

text: Homo sapiens

text: male

characteristic: sex

text: current smoker

text: IV

text: IV

text: <= 6

text: Sample 182

characteristic: title


E-MTAB-5749:Sample 185

text: MRC Toxicology Unit

text: public

text: E-MTAB-5749:Sample 185

text: ArrayExpress

text: Eastern Europe/Russia

text: human

text: Docetaxel

characteristic: compound

characteristic: cycles of chemotherapy treatment

characteristic: description

characteristic: disease progression (binary)

characteristic: eastern cooperative oncology group performance status

text: White

characteristic: ethnic group

text: adenocarcinoma

characteristic: histology

characteristic: lactate dehydrogenase measurement

text: Homo sapiens

text: Homo sapiens

text: blood

characteristic: organism part

text: censored

characteristic: organism status

characteristic: overall survival

characteristic: progression free survival

text: Homo sapiens

text: male

text: current smoker

characteristic: smoking status

text: IV

characteristic: stage at collection

text: IV

characteristic: stage at diagnosis

text: > 6

characteristic: time since diagnosis of advanced disease

text: Sample 185


E-MTAB-5749:Sample 191

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: MRC Toxicology Unit

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: E-MTAB-5749:Sample 191

characteristic: Submitter Id

text: ArrayExpress

characteristic: broker name

text: Western Europe

characteristic: collection site

text: human

characteristic: common name

text: Docetaxel

text: White

text: adenocarcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: blood

text: death

text: Homo sapiens

text: male

characteristic: sex

text: never smoked

text: IV

text: IV

text: > 6

text: Sample 191

characteristic: title


E-MTAB-5749:Sample 199

text: MRC Toxicology Unit

text: public

text: E-MTAB-5749:Sample 199

text: ArrayExpress

text: Eastern Europe/Russia

text: human

text: Docetaxel

characteristic: compound

characteristic: cycles of chemotherapy treatment

characteristic: description

characteristic: disease progression (binary)

characteristic: eastern cooperative oncology group performance status

text: White

characteristic: ethnic group

text: adenocarcinoma

characteristic: histology

characteristic: lactate dehydrogenase measurement

text: Homo sapiens

text: Homo sapiens

text: blood

characteristic: organism part

text: death

characteristic: organism status

characteristic: overall survival

characteristic: progression free survival

text: Homo sapiens

text: male

text: past smoker

characteristic: smoking status

text: IV

characteristic: stage at collection

text: IV

characteristic: stage at diagnosis

text: <= 6

characteristic: time since diagnosis of advanced disease

text: Sample 199


E-MTAB-5749:Sample 2

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: MRC Toxicology Unit

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: E-MTAB-5749:Sample 2

characteristic: Submitter Id

text: ArrayExpress

characteristic: broker name

text: Eastern Europe/Russia

characteristic: collection site

text: human

characteristic: common name

text: Docetaxel

text: White

text: adenocarcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: blood

text: death

text: Homo sapiens

text: male

characteristic: sex

text: past smoker

text: IV

text: IV

text: > 6

text: Sample 2

characteristic: title


E-MTAB-5749:Sample 201

text: MRC Toxicology Unit

text: public

text: E-MTAB-5749:Sample 201

text: ArrayExpress

text: Eastern Europe/Russia

text: human

text: Docetaxel

characteristic: compound

characteristic: cycles of chemotherapy treatment

characteristic: description

characteristic: disease progression (binary)

characteristic: eastern cooperative oncology group performance status

text: White

characteristic: ethnic group

text: adenocarcinoma

characteristic: histology

characteristic: lactate dehydrogenase measurement

text: Homo sapiens

text: Homo sapiens

text: blood

characteristic: organism part

text: death

characteristic: organism status

characteristic: overall survival

characteristic: progression free survival

text: Homo sapiens

text: male

text: past smoker

characteristic: smoking status

text: IV

characteristic: stage at collection

text: IV

characteristic: stage at diagnosis

text: > 6

characteristic: time since diagnosis of advanced disease

text: Sample 201


E-MTAB-5749:Sample 203

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: MRC Toxicology Unit

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: E-MTAB-5749:Sample 203

characteristic: Submitter Id

text: ArrayExpress

characteristic: broker name

text: Eastern Europe/Russia

characteristic: collection site

text: human

characteristic: common name

text: Docetaxel

text: White

text: adenocarcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: blood

text: death

text: Homo sapiens

text: male

characteristic: sex

text: past smoker

text: IV

text: IIIB

text: > 6

text: Sample 203

characteristic: title


E-MTAB-5749:Sample 204

text: MRC Toxicology Unit

text: public

text: E-MTAB-5749:Sample 204

text: ArrayExpress

text: Eastern Europe/Russia

text: human

text: Docetaxel

characteristic: compound

characteristic: cycles of chemotherapy treatment

characteristic: description

characteristic: disease progression (binary)

characteristic: eastern cooperative oncology group performance status

text: White

characteristic: ethnic group

text: adenocarcinoma

characteristic: histology

characteristic: lactate dehydrogenase measurement

text: Homo sapiens

text: Homo sapiens

text: blood

characteristic: organism part

text: death

characteristic: organism status

characteristic: overall survival

characteristic: progression free survival

text: Homo sapiens

text: male

text: current smoker

characteristic: smoking status

text: IV

characteristic: stage at collection

text: IV

characteristic: stage at diagnosis

text: > 6

characteristic: time since diagnosis of advanced disease

text: Sample 204